
-
1997
Company Description
Oxagen is a biopharmaceutical company developing small molecule drugs addressing asthma, and chronic allergic and inflammatory conditions.
Oxagen Limited, a biopharmaceutical company, provides drug discovery and development solutions. It offers molecule drugs for the treatment of asthma, autoimmune disease, inflammatory bowel, psoriasis, allergy, and rheumatoid arthritis diseases. Oxagen Limited was founded in 1997 and is based in Abingdon, the United Kingdom.
-
Manufacturer:
Science and Engineering -
Formed:
1997 -
Founders:
John Bell -
Company Website:
-
Company E-mail:
-
Company Address:
91 Milton ParkUnited KingdomAbingdon -
CEO:
- John Bell
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits